Irving, TX--RBC Life Sciences (OTCBB: RBCL) today announced that it has appointed Ann Billings to the position of Vice President of Marketing.
"We are delighted to attain the talent of an executive whose background is so flawlessly suited to that of RBC, both domestically and internationally," stated John W. Price, President of RBC Life Sciences. "Presently, more than 50 percent of our business is outside of North America and we are confident that Ann's experience in international marketing will help us to further broaden our presence overseas."
Prior to joining RBC Life Sciences, Ann served as the Director of Health and Beauty for Tahitian Noni International. Additionally, she has served as Senior Manager of Product Marketing & Development for a major company that markets nutritional supplements similar to the core business of RBC.
Mr. Price continued, "We feel very fortunate to have Ann as a key member of our Marketing Team. She brings a unique skill set that includes responsibilities in formulation, packaging and international regulatory compliance. In addition, she was the international spokesperson for Tahitian Noni promoting the brand on a worldwide basis, including the markets of Asia, Europe and South America."
RBC Life Sciences develops, manufactures and markets skin care products and food supplements providing nutrients often found to be low or missing in modern diets. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed.
MPM Medical, a wholly owned subsidiary of RBC, develops and markets proprietary prescription and nonprescription products for wound and pain management. MPM products are sold through medical-surgical dealers to nursing homes, hospitals and cancer clinics. For more information on the company, visit www.RBCLifeSciences.com.
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Factors that could contribute to such differences are disclosed in the Company's annual report on Form 10-K, quarterly reports on Form 10-Q, and other reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates and expectations as of the date of the press release, and subsequent events and developments may cause the Company's estimates and expectations to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates and expectations of its future financial performance as of any date subsequent to the date of this press release.
Contact:
Jeff Elliott or Chase Zavoina
Halliburton Investor Relations
search blogs
share it
blog it
